India vs Big Pharma: Compulsory licence for leukaemia drug sought
That the compulsory licence verdict in favour of NATCO Pharma would change the landscape of the pharma industries the world over was never in doubt. The verdict was hailed as ‘revolutionary’,...
View ArticleFree drugs for all?
The government proposes to give away free medicines through government hospitals and health centres. This was announced by Prime Minister Manmohan Singh in his address to the nation on Independence...
View ArticleHow you can prevent cervical cancer
Cervical cancer is known to be spread by a virus called the Human Papilloma Virus (HPV) during sexual contact. We’ve told you about its causes and symptoms, screening including Pap smears. Here are are...
View ArticleTen cancer myths debunked
Cancer myths have been around since the disease itself. While being diagnosed with cancer isn’t great news, the disease is by no means inoperable or incurable. There are lots of myths and...
View ArticleGeneric Drugs – what you need to know
India’s the global leader in the generic market with Indian drugs popular in Africa and other emerging markets. Some Indian pharmaceuticals have even made headway in the USA market. So what are...
View ArticleIndia vs Big Pharma: Bayer loses compulsory licencing verdict
Compulsory licences are here to stay. The Intellectual Property Appellate Board (IPAB) on Monday upheld the country’s first compulsory licence to the Hyderabad based NATCO Pharma for Bayer’s cancer...
View Article‘Compulsory licence verdict a triumph for humanity’
In what has been billed as landmark ruling the Intellectual Property Appellate Board upheld the country’s first compulsory licence to NATCO Pharma for Bayer’s cancer drug Nexavar recently. In layman...
View Article